Adam Anand Row
Gamuda Laboratories has set the groundwork for a new phase of medical service offerings within the Gamuda group. It’s the COVID-19 Polymerase Chain Reaction (PCR) Testing and Elecsys® Anti-SARS-CoV-2 assay test (for the quantitative determination of antibodies to the SARS-CoV-2 spike protein) offerings to commercial entities and the public.
This comes ahead of the soon-to-be-launched Gamuda Clinics, which aims to provide generalised and specialised outpatient medical services at affordable prices. It is the natural evolution of Gamuda’s focus and commitment to the health and safety of its employees and their families throughout the COVID-19 pandemic and beyond.
The two Gamuda Clinics are located at MGKT ERT Yard at Jalan Chan Sow Lin, Sungai Besi and Menara Gamuda (formerly Cafe Toscana); offering medical services first to Gamuda Group employees before being opened to the public later. By bringing employee health management in-house, treatment costs can be lowered while also increasing the quality of healthcare provided.
As explained by Dr Gayathrie Sadacharamani, MGJV Medical Services Manager, “At Gamuda Clinics, our aim is to treat our patients like family with a priority on providing high-quality treatment. We’ve taken great care to ensure everything from the design and ambience of our clinics, to getting the right care and attention to specific to needs by our medical staff, provides a welcoming and attentive patient experience.”
Gamuda Laboratories is equipped with state-of-the-art testing equipment to ensure accurate test results.
Each sample is carefully tested by our experienced in-house medical technicians using world class safety protocols.